Empa MAN Duo

Therapeutic Class

: Oral Hypoglycemic Agent

Manufacturer

: PMI

Country of origin

: Myanmar

Packaging

: 3 x 10’s Tablets

Dosage

: As prescribed by the physicians

Chemical composition

: Each tablet contains Empagliflozin 12.5 mg and Metformin HCL 500 mg

Indications

: to improve glycemic control in adults with type 2 diabetes (T2DM) when diet, exercise, and treatment with either component alone or in combination do not achieve adequate control. It is also used to reduce risks of cardiovascular death and hospitalization.